cefoxitin and Chronic-Pain

cefoxitin has been researched along with Chronic-Pain* in 1 studies

Trials

1 trial(s) available for cefoxitin and Chronic-Pain

Article	Year
Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study. Sexually transmitted diseases, 2011, Volume: 38, Issue:9 PEACH trial data were used to evaluate the relationship between subsequent sexually transmitted infection and recurrent pelvic inflammatory disease on infertility and chronic pelvic pain (CPP). Recurrent pelvic inflammatory disease was associated with an almost 2-fold increase in infertility and more than 4-fold increase in CPP. Subsequent sexually transmitted infection was associated with CPP, but not infertility. Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefoxitin; Chronic Pain; Doxycycline; Female; Follow-Up Studies; Humans; Infertility, Female; Pelvic Inflammatory Disease; Pelvic Pain; Pregnancy; Pregnancy Complications; Probenecid; Recurrence; Reproductive Health; Sexually Transmitted Diseases; Treatment Outcome; United States; Uricosuric Agents; Young Adult	2011

Article

Year

Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study.

Sexually transmitted diseases, 2011, Volume: 38, Issue:9

PEACH trial data were used to evaluate the relationship between subsequent sexually transmitted infection and recurrent pelvic inflammatory disease on infertility and chronic pelvic pain (CPP). Recurrent pelvic inflammatory disease was associated with an almost 2-fold increase in infertility and more than 4-fold increase in CPP. Subsequent sexually transmitted infection was associated with CPP, but not infertility.

Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefoxitin; Chronic Pain; Doxycycline; Female; Follow-Up Studies; Humans; Infertility, Female; Pelvic Inflammatory Disease; Pelvic Pain; Pregnancy; Pregnancy Complications; Probenecid; Recurrence; Reproductive Health; Sexually Transmitted Diseases; Treatment Outcome; United States; Uricosuric Agents; Young Adult

2011